Motilal Oswal Picks Ipca Labs, Hindalco as Top Stocks for March 2026 Week
Motilal Oswal Recommends Ipca Labs, Hindalco for March 2026

Motilal Oswal Identifies Top Stock Picks for March 2026 Week

Motilal Oswal Wealth Management Research Desk has released its weekly stock recommendations, highlighting Ipca Laboratories and Hindalco as the top picks for the week commencing March 23, 2026. This selection is based on detailed analysis of growth prospects, market positioning, and strategic initiatives that could drive significant upside potential for investors.

Ipca Laboratories: Strengthening Portfolio and Export Growth

Ipca Laboratories is currently trading at a current market price (CMP) of Rs 1545, with a target price set at Rs 1820, indicating an upside of 18%. The company is experiencing improved growth visibility, primarily driven by a recovery in its domestic formulations business and a gradual increase in export activities.

Key factors supporting this outlook include:

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list
  • Therapy Expansion: Ipca is enhancing its domestic portfolio through expansions in cardiology and pain management therapies, along with an entry into high-end dermatology segments.
  • Brand Reinforcement: The company is focusing on strengthening key brands such as Zerodol to boost market presence and customer loyalty.
  • Export Support: Export growth is bolstered by rising traction in branded markets and a steady ramp-up in generics, supported by product relaunches in the United States and participation in European tenders.

Additionally, the integration of the Unichem business is progressing, with efforts aimed at improving cost efficiencies through API integration and rebuilding the product pipeline. While near-term performance may face challenges due to pricing pressures, overall improvements in operating leverage, portfolio optimization, and execution across segments position Ipca Laboratories for steady earnings growth in the coming periods.

Hindalco: Capitalizing on Structural Demand Trends

Hindalco is trading at a CMP of Rs 874, with a target price of Rs 1110, suggesting a substantial upside of 27%. The company remains well-positioned to benefit from structural demand tailwinds in the aluminum and copper sectors, driven by global trends such as electrification, renewable energy adoption, infrastructure development, and electric vehicle proliferation.

In India, where growth continues to outpace global averages, Hindalco's strategic initiatives include:

  • Backward Integration: Focus on captive coal mines and renewable energy sources to enhance cost efficiency and margin resilience.
  • Expansion Efforts: Ongoing investments in both upstream and downstream segments, coupled with an increasing share of value-added products, support long-term profitability and diversification.

However, near-term performance may be impacted by temporary disruptions at Novelis, including issues at the Oswego plant and elevated capital intensity. Despite these challenges, Hindalco's strong balance sheet, improving domestic operations, and long-term growth visibility underpin a constructive outlook for investors seeking exposure to the metals and mining sector.

Disclaimer: Recommendations and views on the stock market, other asset classes, or personal finance management tips provided by experts are their own and do not represent the views of The Times of India or affiliated entities. Investors are advised to conduct their own research and consult financial advisors before making investment decisions.

Pickt after-article banner — collaborative shopping lists app with family illustration